Patents by Inventor Deborah Maguire

Deborah Maguire has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Monoclonal antibodies against the interferon receptor, with neutralizing activity against type I interferon
    Patent number: 7465451
    Abstract: The invention relates to a monoclonal antibody directed against the human interferon class I receptor (IFN-R) characterized by the following properties: it recognizes the extracellular domain of the human IFN-R, and it has a neutralizing capacity against the biological properties of the human type I-IFN. It further concerns their use for the diagnosis.
    Type: Grant
    Filed: December 27, 2006
    Date of Patent: December 16, 2008
    Assignee: Medarex, Inc.
    Inventors: Patrick Benoit, Francois Meyer, Deborah Maguire, Ivan Plavec, Michael Gerard Tovey
  • Monoclonal Antibodies Against The Interferon Receptor, With Neutralizing Activity Against Type I Interferon
    Publication number: 20080226647
    Abstract: The invention relates to a monoclonal antibody directed against the human interferon class I receptor (IFN-R) characterized by the following properties: it recognizes the extracellular domain of the human IFN-R, and it has a neutralizing capacity against the biological properties of the human type I-IFN. It further concerns their use for the diagnosis.
    Type: Application
    Filed: May 9, 2008
    Publication date: September 18, 2008
    Applicant: Medarex, Inc.
    Inventors: Patrick Benoit, Francois Meyer, Deborah Maguire, Ivan Plavec, Michael G. Tovey
  • MONOCLONAL ANTIBODIES AGAINST THE INTERFERON RECEPTOR, WITH NEUTRALIZING ACTIVITY AGAINST TYPE I INTERFERON
    Publication number: 20070128701
    Abstract: The invention relates to a monoclonal antibody directed against the human interferon class I receptor (IFN-R) characterized by the following properties: it recognizes the extracellular domain of the human IFN-R, and it has a neutralizing capacity against the biological properties of the human type I-IFN. It further concerns their use for the diagnosis.
    Type: Application
    Filed: December 27, 2006
    Publication date: June 7, 2007
    Applicant: Medarex, Inc.
    Inventors: Patrick Benoit, Francois Meyer, Deborah Maguire, Ivan Plavec, Michael Tovey
  • Monoclonal antibodies against the interferon receptor, with neutralizing activity against type 1 interferon
    Patent number: 7179465
    Abstract: The invention relates to a monoclonal antibody directed against the human interferon class I receptor (IFN-R) characterized by the following properties: it recognizes the extracellular domain of the human IFN-R, and it has a neutralizing capacity against the biological properties of the human type I-IFN. It further concerns their use for the diagnosis.
    Type: Grant
    Filed: April 14, 2004
    Date of Patent: February 20, 2007
    Assignee: Medarex, Inc.
    Inventors: Patrick Benoit, Francois Meyer, Deborah Maguire, Ivan Plavec, Michael G. Tovey
  • Monoclonal antibodies against the interferon receptor, with neutralizing activity against type I interferon
    Publication number: 20040191840
    Abstract: The invention relates to a monoclonal antibody directed against the human interferon class I receptor (IFN-R) characterized by the following properties: it recognizes the extracellular domain of the human IFN-R, and it has a neutralizing capacity against the biological properties of the human type I-IFN. It further concerns their use for the diagnosis.
    Type: Application
    Filed: April 14, 2004
    Publication date: September 30, 2004
    Inventors: Patrick Benoit, Francois Meyer, Deborah Maguire, Ivan Plavec, Michael G. Tovey